Skip to main content
Erschienen in: Supportive Care in Cancer 4/2016

01.04.2016 | Original Article

Health-related quality of life of Chinese patients with prostate cancer in comparison to general population and other cancer populations

verfasst von: Edmond P. H. Choi, Carlos K. H. Wong, James H. L. Tsu, W. Y. Chin, Kenny Kung, Charles K. W. Wong, M. K. Yiu

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study was to compare the health-related quality of life (HRQOL) of Chinese patients with prostate cancer against the general population and patients with colorectal cancer, breast cancer, nasopharyngeal cancer, and leukemia.

Methods

Chinese male patients (n = 291) with a confirmed diagnosis of prostate cancer were recruited from a urological specialist outpatient clinic in Hong Kong. HRQOL was measured by a condition-specific Functional Assessment of Cancer Therapy-Prostate (FACT-P) and a generic Chinese (HK) SF-12 Health Survey Version 2 (SF-12v2) questionnaire. Mean HRQOL scores of condition-specific and generic questionnaires were compared to available scores derived from other cancers and age-matched male general population, respectively.

Results

Chinese patients with prostate cancer had lower general health and vitality domains and lower mental component summary scores than the age-matched Hong Kong normative population. Patients with prostate cancer reported better condition-specific HRQOL (physical well-being, emotional well-being and function well-being) when compared to general cancer population, patients with breast cancer, colorectal cancer, nasopharyngeal cancer, and leukemia in Hong Kong.

Conclusions

Patients with prostate cancer substantially perceived their HRQOL to be better, compared to patients with other cancers, with overall health, energy, and mental health below of Hong Kong general population. Interventions should target at these domains in order to improve the HRQOL of patients with prostate cancer. It is reassuring to find that prostate cancer had less negative impact on HRQOL than other cancer types did.
Literatur
1.
Zurück zum Zitat Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer Journal International du Cancer 127(12):2893–2917. doi:10.1002/ijc.25516 CrossRefPubMed Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer Journal International du Cancer 127(12):2893–2917. doi:10.​1002/​ijc.​25516 CrossRefPubMed
3.
Zurück zum Zitat Bouchardy C, Fioretta G, Rapiti E, Verkooijen HM, Rapin CH, Schmidlin F, Miralbell R, Zanetti R (2008) Recent trends in prostate cancer mortality show a continuous decrease in several countries. International Journal of Cancer Journal International du Cancer 123(2):421–429. doi:10.1002/ijc.23520 CrossRefPubMed Bouchardy C, Fioretta G, Rapiti E, Verkooijen HM, Rapin CH, Schmidlin F, Miralbell R, Zanetti R (2008) Recent trends in prostate cancer mortality show a continuous decrease in several countries. International Journal of Cancer Journal International du Cancer 123(2):421–429. doi:10.​1002/​ijc.​23520 CrossRefPubMed
4.
Zurück zum Zitat Kronenwetter C, Weidner G, Pettengill E, Marlin R, Crutchfield L, McCormac P, Raisin CJ, Ornish D (2005) A qualitative analysis of interviews of men with early stage prostate cancer: the prostate cancer lifestyle trial. Cancer Nurs 28(2):99–107CrossRefPubMed Kronenwetter C, Weidner G, Pettengill E, Marlin R, Crutchfield L, McCormac P, Raisin CJ, Ornish D (2005) A qualitative analysis of interviews of men with early stage prostate cancer: the prostate cancer lifestyle trial. Cancer Nurs 28(2):99–107CrossRefPubMed
5.
Zurück zum Zitat Krupski TL, Fink A, Kwan L, Maliski S, Connor SE, Clerkin B, Litwin MS (2005) Health-related quality-of-life in low-income, uninsured men with prostate cancer. J Health Care Poor Underserved 16(2):375–390. doi:10.1353/hpu.2005.0037 CrossRefPubMed Krupski TL, Fink A, Kwan L, Maliski S, Connor SE, Clerkin B, Litwin MS (2005) Health-related quality-of-life in low-income, uninsured men with prostate cancer. J Health Care Poor Underserved 16(2):375–390. doi:10.​1353/​hpu.​2005.​0037 CrossRefPubMed
6.
Zurück zum Zitat Penson DF, Litwin MS, Aaronson NK (2003) Health related quality of life in men with prostate cancer. J Urol 169(5):1653–1661CrossRefPubMed Penson DF, Litwin MS, Aaronson NK (2003) Health related quality of life in men with prostate cancer. J Urol 169(5):1653–1661CrossRefPubMed
7.
8.
Zurück zum Zitat Ishihara M, Suzuki H, Akakura K, Komiya A, Imamoto T, Tobe T, Ichikawa T (2006) Baseline health-related quality of life in the management of prostate cancer. International Journal of Urology : Official Journal of the Japanese Urological Association 13(7):920–925. doi:10.1111/j.1442-2042.2006.01441.x CrossRef Ishihara M, Suzuki H, Akakura K, Komiya A, Imamoto T, Tobe T, Ichikawa T (2006) Baseline health-related quality of life in the management of prostate cancer. International Journal of Urology : Official Journal of the Japanese Urological Association 13(7):920–925. doi:10.​1111/​j.​1442-2042.​2006.​01441.​x CrossRef
9.
Zurück zum Zitat Rosenfeld B, Roth AJ, Gandhi S, Penson D (2004) Differences in health-related quality of life of prostate cancer patients based on stage of cancer. Psycho-Oncology 13(11):800–807CrossRefPubMed Rosenfeld B, Roth AJ, Gandhi S, Penson D (2004) Differences in health-related quality of life of prostate cancer patients based on stage of cancer. Psycho-Oncology 13(11):800–807CrossRefPubMed
10.
Zurück zum Zitat Zenger M, Lehmann-Laue A, Stolzenburg JU, Schwalenberg T, Ried A, Hinz A (2010) The relationship of quality of life and distress in prostate cancer patients compared to the general population. Psycho-social medicine 7:Doc02. doi:10.3205/psm000064 PubMedCentralPubMed Zenger M, Lehmann-Laue A, Stolzenburg JU, Schwalenberg T, Ried A, Hinz A (2010) The relationship of quality of life and distress in prostate cancer patients compared to the general population. Psycho-social medicine 7:Doc02. doi:10.​3205/​psm000064 PubMedCentralPubMed
11.
Zurück zum Zitat Ashing-Giwa KT (2005) The contextual model of HRQoL: a paradigm for expanding the HRQoL framework. Qual Life Res 14(2):297–307CrossRefPubMed Ashing-Giwa KT (2005) The contextual model of HRQoL: a paradigm for expanding the HRQoL framework. Qual Life Res 14(2):297–307CrossRefPubMed
12.
Zurück zum Zitat Choi EP, Lam CL, Chin WY (2014) The health-related quality of life of Chinese patients with lower urinary tract symptoms in primary care. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 23(10):2723–2733. doi:10.1007/s11136-014-0725-5 CrossRef Choi EP, Lam CL, Chin WY (2014) The health-related quality of life of Chinese patients with lower urinary tract symptoms in primary care. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 23(10):2723–2733. doi:10.​1007/​s11136-014-0725-5 CrossRef
13.
Zurück zum Zitat Wong CKH, Choi EPH, Tsu JHL, Ho BSH, Ng ATL, Chin WY, Yiu MK (2015) Psychometric properties of functional assessment of cancer therapy-prostate (FACT-P) in Chinese patients with prostate cancer. Quality of Life Research 24(10):2397–2402. doi:10.1007/s11136-015-0993-8 Wong CKH, Choi EPH, Tsu JHL, Ho BSH, Ng ATL, Chin WY, Yiu MK (2015) Psychometric properties of functional assessment of cancer therapy-prostate (FACT-P) in Chinese patients with prostate cancer. Quality of Life Research 24(10):2397–2402. doi:10.​1007/​s11136-015-0993-8
14.
Zurück zum Zitat Ware JE, Kosinski M, Keller SD (1995) SF-12: how to score the SF-12 physical and mental health summary scales. Health Institute, New England Medical Center Ware JE, Kosinski M, Keller SD (1995) SF-12: how to score the SF-12 physical and mental health summary scales. Health Institute, New England Medical Center
16.
Zurück zum Zitat Lam CL, Wong CH, Lam ET, Lo YY, Huang WW (2010) Population norm of Chinese (HK) SF-12 health survey-version 2 of Chinese adults in Hong Kong. Hong Kong Practitioner 32(2):77–86 Lam CL, Wong CH, Lam ET, Lo YY, Huang WW (2010) Population norm of Chinese (HK) SF-12 health survey-version 2 of Chinese adults in Hong Kong. Hong Kong Practitioner 32(2):77–86
17.
18.
Zurück zum Zitat Patrick DL, Deyo RA (1989) Generic and disease-specific measures in assessing health status and quality of life. Medical care:S217-S232 Patrick DL, Deyo RA (1989) Generic and disease-specific measures in assessing health status and quality of life. Medical care:S217-S232
19.
Zurück zum Zitat Yu CL, Fielding R, Chan CL, Tse VK, Choi PH, Lau WH, Choy DT, SK O, Lee AW, Sham JS (2000) Measuring quality of life of Chinese cancer patients: a validation of the Chinese version of the Functional Assessment of Cancer Therapy-General (FACT-G) scale. Cancer 88(7):1715–1727CrossRefPubMed Yu CL, Fielding R, Chan CL, Tse VK, Choi PH, Lau WH, Choy DT, SK O, Lee AW, Sham JS (2000) Measuring quality of life of Chinese cancer patients: a validation of the Chinese version of the Functional Assessment of Cancer Therapy-General (FACT-G) scale. Cancer 88(7):1715–1727CrossRefPubMed
20.
Zurück zum Zitat Yu CL, Fielding R, Chan CL (2003) The mediating role of optimism on post-radiation quality of life in nasopharyngeal carcinoma. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 12(1):41–51CrossRef Yu CL, Fielding R, Chan CL (2003) The mediating role of optimism on post-radiation quality of life in nasopharyngeal carcinoma. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 12(1):41–51CrossRef
21.
Zurück zum Zitat Wong WS, Fielding R (2007) Change in quality of life in Chinese women with breast cancer: changes in psychological distress as a predictor. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 15(11):1223–1230. doi:10.1007/s00520-006-0190-y CrossRef Wong WS, Fielding R (2007) Change in quality of life in Chinese women with breast cancer: changes in psychological distress as a predictor. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 15(11):1223–1230. doi:10.​1007/​s00520-006-0190-y CrossRef
23.
Zurück zum Zitat Lau AK, Chang CH, Tai JW, Eremenco S, Liang R, Lie AK, Fong DY, Lau CM (2002) Translation and validation of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) Version 4 quality of life instrument into traditional Chinese. Bone Marrow Transplant 29(1):41–49. doi:10.1038/sj.bmt.1703313 CrossRefPubMed Lau AK, Chang CH, Tai JW, Eremenco S, Liang R, Lie AK, Fong DY, Lau CM (2002) Translation and validation of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) Version 4 quality of life instrument into traditional Chinese. Bone Marrow Transplant 29(1):41–49. doi:10.​1038/​sj.​bmt.​1703313 CrossRefPubMed
26.
Zurück zum Zitat Thomas JC, Hersen M (2011) Understanding research in clinical and counseling psychology. Taylor & Francis Thomas JC, Hersen M (2011) Understanding research in clinical and counseling psychology. Taylor & Francis
32.
Zurück zum Zitat Basaria S, Lieb 2nd J, Tang AM, DeWeese T, Carducci M, Eisenberger M, Dobs AS (2002) Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol 56(6):779–786CrossRef Basaria S, Lieb 2nd J, Tang AM, DeWeese T, Carducci M, Eisenberger M, Dobs AS (2002) Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol 56(6):779–786CrossRef
34.
Zurück zum Zitat Leung PC (2010) Healthy aging. World Scientific Publishing Company, Singapore Leung PC (2010) Healthy aging. World Scientific Publishing Company, Singapore
35.
Zurück zum Zitat Lahans T (2007) Integrating conventional and Chinese medicine in cancer care: a clinical guide. Churchill Livingstone, Edinburgh Lahans T (2007) Integrating conventional and Chinese medicine in cancer care: a clinical guide. Churchill Livingstone, Edinburgh
36.
Zurück zum Zitat Bjorner JB, Wallenstein GV, Martin MC, Lin P, Blaisdell-Gross B, Tak Piech C, Mody SH (2007) Interpreting score differences in the SF-36 vitality scale: using clinical conditions and functional outcomes to define the minimally important difference. Curr Med Res Opin 23(4):731–739. doi:10.1185/030079907X178757 CrossRefPubMed Bjorner JB, Wallenstein GV, Martin MC, Lin P, Blaisdell-Gross B, Tak Piech C, Mody SH (2007) Interpreting score differences in the SF-36 vitality scale: using clinical conditions and functional outcomes to define the minimally important difference. Curr Med Res Opin 23(4):731–739. doi:10.​1185/​030079907X178757​ CrossRefPubMed
37.
Zurück zum Zitat Sprangers MA, Schwartz CE (1999) Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med 48(11):1507–1515CrossRefPubMed Sprangers MA, Schwartz CE (1999) Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med 48(11):1507–1515CrossRefPubMed
38.
Zurück zum Zitat Efficace F, Kemmler G, Vignetti M, Mandelli F, Molica S, Holzner B (2008) Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials—a systematic review to evaluate the added value in supporting clinical decision making. Eur J Cancer 44(11):1497–1506. doi:10.1016/j.ejca.2008.03.017 CrossRefPubMed Efficace F, Kemmler G, Vignetti M, Mandelli F, Molica S, Holzner B (2008) Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials—a systematic review to evaluate the added value in supporting clinical decision making. Eur J Cancer 44(11):1497–1506. doi:10.​1016/​j.​ejca.​2008.​03.​017 CrossRefPubMed
39.
Zurück zum Zitat Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ (2000) Patient reports of complications of bone marrow transplantation. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 8(1):33–39 Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ (2000) Patient reports of complications of bone marrow transplantation. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 8(1):33–39
40.
Zurück zum Zitat Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, Brook RH (1995) Quality-of-life outcomes in men treated for localized prostate cancer. Jama 273(2):129–135CrossRefPubMed Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, Brook RH (1995) Quality-of-life outcomes in men treated for localized prostate cancer. Jama 273(2):129–135CrossRefPubMed
41.
Zurück zum Zitat Brandeis JM, Litwin MS, Burnison CM, Reiter RE (2000) Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol 163(3):851–857CrossRefPubMed Brandeis JM, Litwin MS, Burnison CM, Reiter RE (2000) Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol 163(3):851–857CrossRefPubMed
42.
Zurück zum Zitat Wei JT, Dunn RL, Sandler HM, McLaughlin PW, Montie JE, Litwin MS, Nyquist L, Sanda MG (2002) Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 20(2):557–566CrossRefPubMed Wei JT, Dunn RL, Sandler HM, McLaughlin PW, Montie JE, Litwin MS, Nyquist L, Sanda MG (2002) Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 20(2):557–566CrossRefPubMed
43.
Zurück zum Zitat Choi E, Lam C, Chin W-Y (2014) Validation of the International Prostate Symptom Score in Chinese males and females with lower urinary tract symptoms. Health Qual Life Outcomes 12(1):1PubMedCentralCrossRefPubMed Choi E, Lam C, Chin W-Y (2014) Validation of the International Prostate Symptom Score in Chinese males and females with lower urinary tract symptoms. Health Qual Life Outcomes 12(1):1PubMedCentralCrossRefPubMed
44.
Zurück zum Zitat Cella D, Nichol MB, Eton D, Nelson JB, Mulani P (2009) Estimating clinically meaningful changes for the functional assessment of cancer therapy—prostate: results from a clinical trial of patients with metastatic hormone-refractory prostate cancer. Value Health 12(1):124–129CrossRefPubMed Cella D, Nichol MB, Eton D, Nelson JB, Mulani P (2009) Estimating clinically meaningful changes for the functional assessment of cancer therapy—prostate: results from a clinical trial of patients with metastatic hormone-refractory prostate cancer. Value Health 12(1):124–129CrossRefPubMed
45.
46.
Zurück zum Zitat Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG, Venner PM, Quinney HA, Jones LW, D’Angelo ME, Wells GA (2003) Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 21(9):1653–1659. doi:10.1200/JCO.2003.09.534 CrossRef Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG, Venner PM, Quinney HA, Jones LW, D’Angelo ME, Wells GA (2003) Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 21(9):1653–1659. doi:10.​1200/​JCO.​2003.​09.​534 CrossRef
47.
Zurück zum Zitat Knols R, Aaronson NK, Uebelhart D, Fransen J, Aufdemkampe G (2005) Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 23(16):3830–3842. doi:10.1200/JCO.2005.02.148 CrossRef Knols R, Aaronson NK, Uebelhart D, Fransen J, Aufdemkampe G (2005) Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 23(16):3830–3842. doi:10.​1200/​JCO.​2005.​02.​148 CrossRef
48.
Zurück zum Zitat Knight SJ, Chmiel JS, Kuzel T, Sharp L, Albers M, Fine R, Moran EM, Nadler RB, Sharifi R, Bennett CL (1998) Quality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and criterion related validity of 3 measures. J Urol 160(5):1765–1769CrossRefPubMed Knight SJ, Chmiel JS, Kuzel T, Sharp L, Albers M, Fine R, Moran EM, Nadler RB, Sharifi R, Bennett CL (1998) Quality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and criterion related validity of 3 measures. J Urol 160(5):1765–1769CrossRefPubMed
49.
Zurück zum Zitat Kim SP, Knight SJ, Tomori C, Colella KM, Schoor RA, Shih L, Kuzel TM, Nadler RB, Bennett CL (2001) Health literacy and shared decision making for prostate cancer patients with low socioeconomic status. Cancer Investig 19(7):684–691CrossRef Kim SP, Knight SJ, Tomori C, Colella KM, Schoor RA, Shih L, Kuzel TM, Nadler RB, Bennett CL (2001) Health literacy and shared decision making for prostate cancer patients with low socioeconomic status. Cancer Investig 19(7):684–691CrossRef
Metadaten
Titel
Health-related quality of life of Chinese patients with prostate cancer in comparison to general population and other cancer populations
verfasst von
Edmond P. H. Choi
Carlos K. H. Wong
James H. L. Tsu
W. Y. Chin
Kenny Kung
Charles K. W. Wong
M. K. Yiu
Publikationsdatum
01.04.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 4/2016
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2980-6

Weitere Artikel der Ausgabe 4/2016

Supportive Care in Cancer 4/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.